Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Outcomes of Treatment and Predictors of Response to Sofosbuvir plus Simeprevir in Hepatitis C Virus with Genotype-4 Infection.

Ossama A Ahmed,Mohamed A Elsebaey,Mohamed Hassan A Fouad,Mahmoud Elkadeem,Rehab Badawi,Ahmed Khayyal,Shaimaa Soliman,Manal Saad Negm,Sherief Abd-Elsalam

Infectious disorders drug targets（2020）

Cited 5|Views4
No score
Abstract
Twelve weeks regimen of sofosbuvir plus simeprevir was considered to be safe and tolerable in treatment of HCV genotype 4; also it was associated with high SVR (97.6%).
More
Translated text
Key words
Genotype 4,HCV,simeprevir.,sofosbuvir
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined